Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction. : J Eur Acad Dermatol Venereol

0 avis

Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction. : J Eur Acad Dermatol Venereol

Archive ouverte

Raschi, E. | Salvo, Francesco | La Placa, M. | Poluzzi, E. | de Ponti, F.

Edité par CCSD ; Wiley -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis. : Vaccine

Archive ouverte | Mouchet, Julie | CCSD

International audience. BACKGROUND: The anti-hepatitis B immunization campaigns launched in the early 1990s were a major public health breakthrough and targeted various populations (at-risk adults, newborns, adolesc...

Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis. : Pharmacol Res

Archive ouverte | Mouchet, Julie | CCSD

International audience. BACKGROUND: Approved in 2006, human papillomavirus (HPV) vaccines were initially targeted for girls aged 9-14 years. Although the safety of these vaccines has been monitored through post-lice...

Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems. : Nutr Metab Cardiovasc Dis

Archive ouverte | Raschi, E. | CCSD

International audience. Sodium-glucose co-transporter-2 inhibitors (SGLT2-Is) have consistently demonstrated a clinically significant reduction of cardiovascular mortality. However, their safety in clinical practice...

Chargement des enrichissements...